View:
Download DOC
Download PDF
Download XLS
Form 8-K Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 3, 2007

ICU Medical, Inc.
(Exact name of registrant as specified in its charter)


DELAWARE 		 
0-19974 		 
33-0022692
(State or other jurisdiction
of incorporation) 		  (Commission File Number)   (IRS Employer Identification No.)


 
951 Calle Amanecer, San Clemente, California 		 
92673 		 
  (Address of principal executive offices)   (Zip Code)  

Registrant's telephone number, including area code:   (949) 366-2183



________________________________________________________________________________
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [   ] Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
  [   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

Following dismissal of the Registrant's claim of patent infringement against Alaris Medical Systems, Inc., the United States District Court for the Central District of California on June 28, 2007 awarded Alaris $4.8 million in fees and costs, plus post judgment interest, pursuant to a motion brought by Alaris.

Item 9.01. Financial Statements and Exhibits.

(c)     Exhibits

99.1  Press release, dated July 3, 2007 entitled, "ICU Medical, Inc. Reports Court Order".

SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ICU Medical, Inc.
(Registrant)
July 3, 2007
(Date) 		  /s/   FRANCIS J. O'BRIEN
Francis J. O'Brien
Secretary, Treasurer and Chief Financial Officer
ICU Medical, Inc. Reports Court Order

EXHIBIT 99.1

ICU Medical, Inc. Reports Court Order

SAN CLEMENTE, Calif., July 3, 2007 (PRIME NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, today announced that the United States District Court for the Central District of California on June 28, 2007 ordered ICU Medical, Inc. to pay Alaris Medical Systems, Inc. (now part of Cardinal Health, Inc.), $4.8 million of fees and costs, plus post judgment interest. The Court's decision was pursuant to a motion brought by Alaris for reimbursement of legal fees following dismissal of ICU Medical's claim of patent infringement against Alaris. ICU Medical intends to appeal the Court's judgment dismissing its claims in the patent case. Because the order is a judgment against ICU Medical and the outcome of the appeal is uncertain, ICU Medical will record a charge of $4.8 million in its financial statements for the quarter ended June 30, 2007. 

CONTACT:  ICU Medical, Inc.
          Francis J. O'Brien, Chief Financial Officer
          (949) 366-2183

          Integrated Corporate Relations
          John F. Mills, Senior Managing Director
          (310) 954-1105